Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Jun;65(6):879–883. doi: 10.1038/bjc.1992.184

Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.

S A Watson 1, D M Crosbee 1, D L Morris 1, J F Robertson 1, F Makovec 1, L C Rovati 1, J D Hardcastle 1
PMCID: PMC1977787  PMID: 1616859

Abstract

The gastrin receptor antagonist, CR2093, competed with 125I-gastrin-17 (5 x 10(-10) M) for binding to gastrin receptors on the rat pancreatic adenocarcinoma, AR42J (CR2093 concentration inducing 50% of 125I-gastrin-17 binding (IC50) was 8 x 10(-5) M), on the human gastric adenocarcinoma, MKN45 (IC50 5.5 x 10(-5) M) and the human colo-rectal adenocarcinoma C523 (IC50 greater than 10(-4) M). Intravenous administration of CR2093 (40 mg kg-1 day-1) reduced the gastrin-17 stimulated growth of AR42J xenografts in nude mice to below that of the original basal growth (P = 0.0166 from basal and P = 0.0109 from gastrin stimulated growth). CR2093 administration also reduced the gastrin-stimulated growth of MKN45 xenografts (P = 0.045) but failed to inhibit the gastrin enhanced proliferation of C523 xenografts. This may be related to the affinity (Kd) of the gastrin receptors present on the xenograft lines as the Kds of the two xenografts inhibited by CR2093 were 4.6 x 10(-10) M (AR42J) and 1.2 x 10(-9) M (MKN45) respectively whereas the Kd of C523 was of higher affinity (2.2 x 10(-10) M). GR antagonists may be a viable therapeutic option for gastrin receptor positive, gastro-intestinal tumours.

Full text

PDF
879

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin G. S., Casey A., Mantamadiotis T., McBride K., Sizeland A. M., Thumwood C. M. PCR cloning and sequence of gastrin mRNA from carcinoma cell lines. Biochem Biophys Res Commun. 1990 Jul 31;170(2):691–697. doi: 10.1016/0006-291x(90)92146-q. [DOI] [PubMed] [Google Scholar]
  2. Furr B. J., Jordan V. C. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther. 1984;25(2):127–205. doi: 10.1016/0163-7258(84)90043-3. [DOI] [PubMed] [Google Scholar]
  3. Hoosein N. M., Kiener P. A., Curry R. C., Brattain M. G. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res. 1990 Jan;186(1):15–21. doi: 10.1016/0014-4827(90)90204-n. [DOI] [PubMed] [Google Scholar]
  4. Hoosein N. M., Kiener P. A., Curry R. C., Rovati L. C., McGilbra D. K., Brattain M. G. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res. 1988 Dec 15;48(24 Pt 1):7179–7183. [PubMed] [Google Scholar]
  5. McGuigan J. E., Trudeau W. L. Serum and tissue gastrin concentrations in patients with carcinoma of the stomach. Gastroenterology. 1973 Jan;64(1):22–25. [PubMed] [Google Scholar]
  6. Motoyama T., Watanabe H. Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice. Gan. 1983 Oct;74(5):679–686. [PubMed] [Google Scholar]
  7. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  8. Scemama J. L., Fourmy D., Zahidi A., Pradayrol L., Susini C., Ribet A. Characterisation of gastrin receptors on a rat pancreatic acinar cell line (AR42J). A possible model for studying gastrin mediated cell growth and proliferation. Gut. 1987;28 (Suppl):233–236. doi: 10.1136/gut.28.suppl.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Singh P., Le S., Beauchamp R. D., Townsend C. M., Jr, Thompson J. C. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist. Cancer Res. 1987 Oct 1;47(19):5000–5004. [PubMed] [Google Scholar]
  10. Singh P., Walker J. P., Townsend C. M., Jr, Thompson J. C. Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice. Cancer Res. 1986 Apr;46(4 Pt 1):1612–1616. [PubMed] [Google Scholar]
  11. Upp J. R., Jr, Singh P., Townsend C. M., Jr, Thompson J. C. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 1989 Jan 15;49(2):488–492. [PubMed] [Google Scholar]
  12. Watson S. A., Durrant L. G., Wencyk P. M., Watson A. L., Morris D. L. Intracellular gastrin in human gastrointestinal tumor cells. J Natl Cancer Inst. 1991 Jun 19;83(12):866–871. doi: 10.1093/jnci/83.12.866. [DOI] [PubMed] [Google Scholar]
  13. Watson S., Durrant L., Elston P., Morris D. Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells. Cancer. 1991 Sep 15;68(6):1255–1260. doi: 10.1002/1097-0142(19910915)68:6<1255::aid-cncr2820680613>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  14. Weinstock J., Baldwin G. S. Binding of gastrin(17) to human gastric carcinoma cell lines. Cancer Res. 1988 Feb 15;48(4):932–937. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES